Clinical trials
Phase 2/3 Prostatic Neoplasms trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 4 |
| Unknown status | 3 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peking Union Medical College Hospital | 2 |
| Eli Lilly and Company | 1 |
| First Affiliated Hospital of Fujian Medical University | 1 |
| Novartis Pharmaceuticals | 1 |
| RenJi Hospital | 1 |
| Shanghai Jiao Tong University School of Medicine | 1 |
| Zhongnan Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Neoplasms | 8 |
| Adenocarcinoma | 1 |
| Carcinoma, Transitional Cell | 1 |
| Cholangiocarcinoma | 1 |
| Endometrial Neoplasms | 1 |
| Head and Neck Neoplasms | 1 |
| Liver Neoplasms | 1 |
| Lung Neoplasms | 1 |
| Nasopharyngeal Neoplasms | 1 |
| Ovarian Neoplasms | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.